-
Something wrong with this record ?
Crystallization and preliminary X-ray diffraction analysis of mouse galectin-4 N-terminal carbohydrate recognition domain in complex with lactose
V Krejcirikova, M Fabry, V Markova, P Maly, P Rezacova, J Brynda
Language English Country Great Britain
NLK
Free Medical Journals
from 2005 to 2013
PubMed Central
from 2005 to 2013
Europe PubMed Central
from 2005 to 2013
Wiley Online Library (archiv)
from 2005-01-01 to 2012-12-31
- MeSH
- Amino Acid Motifs MeSH
- X-Ray Diffraction MeSH
- Financing, Organized MeSH
- Galectin 4 chemistry metabolism MeSH
- Crystallization MeSH
- Lactose chemistry metabolism MeSH
- Ligands MeSH
- Mice MeSH
- Biomarkers, Tumor chemistry metabolism MeSH
- Colonic Neoplasms chemistry metabolism MeSH
- Peptide Fragments chemistry metabolism MeSH
- Protein Structure, Tertiary MeSH
- Binding Sites MeSH
- Animals MeSH
- Check Tag
- Mice MeSH
- Animals MeSH
Galectin-4 is thought to play a role in the process of tumour conversion of cells of the alimentary tract and the breast tissue; however, its exact function remains unknown. With the aim of elucidating the structural basis of mouse galectin-4 (mGal-4) binding specificity, we have undertaken X-ray analysis of the N-terminal domain, CRD1, of mGal-4 in complex with lactose (the basic building block of known galectin-4 carbohydrate ligands). Crystals of CRD1 in complex with lactose were obtained using vapour-diffusion techniques. The crystals belong to tetragonal space group P42(1)2 with unit-cell parameters a = 91.1, b = 91.16, c = 57.10 A and preliminary X-ray diffraction data were collected to 3.2 A resolution. An optimized crystallization procedure and cryocooling protocol allowed us to extend resolution to 2.1 A. Structure refinement is currently under way; the initial electron-density maps clearly show non-protein electron density in the vicinity of the carbohydrate binding site, indicating the presence of one lactose molecule. The structure will help to improve understanding of the binding specificity and function of the potential colon cancer marker galectin-4.
References provided by Crossref.org
- 000
- 03186naa 2200481 a 4500
- 001
- bmc11004693
- 003
- CZ-PrNML
- 005
- 20121114115813.0
- 008
- 110309s2008 xxk e eng||
- 009
- AR
- 024 __
- $a 10.1107/s1744309108017405 $2 doi
- 035 __
- $a (PubMed)18607104
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Krejčiříková, Veronika $7 xx0128639
- 245 10
- $a Crystallization and preliminary X-ray diffraction analysis of mouse galectin-4 N-terminal carbohydrate recognition domain in complex with lactose / $c V Krejcirikova, M Fabry, V Markova, P Maly, P Rezacova, J Brynda
- 314 __
- $a Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, Flemingovo nam. 2, 166 37 Praha 6, Czech Republic.
- 520 9_
- $a Galectin-4 is thought to play a role in the process of tumour conversion of cells of the alimentary tract and the breast tissue; however, its exact function remains unknown. With the aim of elucidating the structural basis of mouse galectin-4 (mGal-4) binding specificity, we have undertaken X-ray analysis of the N-terminal domain, CRD1, of mGal-4 in complex with lactose (the basic building block of known galectin-4 carbohydrate ligands). Crystals of CRD1 in complex with lactose were obtained using vapour-diffusion techniques. The crystals belong to tetragonal space group P42(1)2 with unit-cell parameters a = 91.1, b = 91.16, c = 57.10 A and preliminary X-ray diffraction data were collected to 3.2 A resolution. An optimized crystallization procedure and cryocooling protocol allowed us to extend resolution to 2.1 A. Structure refinement is currently under way; the initial electron-density maps clearly show non-protein electron density in the vicinity of the carbohydrate binding site, indicating the presence of one lactose molecule. The structure will help to improve understanding of the binding specificity and function of the potential colon cancer marker galectin-4.
- 650 _2
- $a aminokyselinové motivy $7 D020816
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a vazebná místa $7 D001665
- 650 _2
- $a nádory tračníku $x chemie $x metabolismus $7 D003110
- 650 _2
- $a krystalizace $7 D003460
- 650 _2
- $a galektin 4 $x chemie $x metabolismus $7 D037541
- 650 _2
- $a laktosa $x chemie $x metabolismus $7 D007785
- 650 _2
- $a ligandy $7 D008024
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a peptidové fragmenty $x chemie $x metabolismus $7 D010446
- 650 _2
- $a terciární struktura proteinů $7 D017434
- 650 _2
- $a nádorové biomarkery $x chemie $x metabolismus $7 D014408
- 650 _2
- $a difrakce rentgenového záření $7 D014961
- 650 _2
- $a financování organizované $7 D005381
- 700 1_
- $a Fábry, Milan, $d 1947- $7 xx0049924
- 700 1_
- $a Marková, Vladimíra $7 xx0094893
- 700 1_
- $a Malý, Petr $7 xx0128744
- 700 1_
- $a Řezáčová, Pavlína $7 xx0119409
- 700 1_
- $a Brynda, Jiří $7 xx0100180
- 773 0_
- $t Acta Crystallographica. Section F, Structural Biology & Crystallization Communications $w MED00179506 $g Roč. 64, č. Pt 7 (2008), s. 665-667
- 910 __
- $a ABA008 $b x $y 1
- 990 __
- $a 20110414093030 $b ABA008
- 991 __
- $a 20121114115829 $b ABA008
- 999 __
- $a ok $b bmc $g 832072 $s 696730
- BAS __
- $a 3
- BMC __
- $a 2008 $b 64 $c Pt 7 $d 665-667 $m Acta crystallographica. Section F $n Acta Crystallogr Sect F Struct Biol Cryst Commun $x MED00179506
- LZP __
- $a 2011-4B/vtme